Home > Journals > Minerva Biotechnology and Biomolecular Research > Past Issues > Minerva Biotechnology and Biomolecular Research 2022 December;34(4) > Minerva Biotechnology and Biomolecular Research 2022 December;34(4):196-203

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Biotechnology and Biomolecular Research 2022 December;34(4):196-203

DOI: 10.23736/S2724-542X.22.02943-1

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Cytokine profile in patients with osteoarthritis after SARS-CoV-2 infection

Daryna KRENYTSKA 1, Larysa KOT 1, Tetiana HALENOVA 1, Nataliia RAKSHA 1, Tetiana VOVK 1, Olexii SAVCHUK 1, Rinaldo PELLICANO 2, Ludovico ABENAVOLI 3, Tetyana FALALYEYEVA 1 , Liudmyla OSTAPCHENKO 1

1 Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; 2 Unit of Gastroenterology, Molinette Hospital, Turin, Italy; 3 Department of Health Sciences, The Magna Græcia University of Catanzaro, Catanzaro, Italy



BACKGROUND: Severe acute respiratory syndrome-related Coronavirus 2 (SARS-CoV-2) іnfection induces a pro-inflammatory state of an organism with long-term systemic consequences as a result. Systemic inflammation, characterized by a high circulating level of inflammatory cytokines, is a significant factor influencing articular cartilage metabolism in osteoarthritis (OA). This study aimed to determine the levels of pro-inflammatory and anti-inflammatory cytokines in plasma of patients with OA following SARS-CoV-2 infection and to compare them with those of healthy controls.
METHODS: The experiment involved patients of the Orthopedic Specialty Clinic aged 46 to 69 diagnosed with knee OA. Among persons with joint pathology a group of convalescent patients from 6-9 months after COVID-19 was identified. The control group involved relatively healthy donors. The plasma levels of pro-inflammatory (IL-1β, IL-6, IL-8, IL-12β, tumor necrosis factor α [TNF-α], interferon-gamma [IFN-γ]) and anti-inflammatory (IL-4 and IL-10) cytokines were determined by enzyme-linked immunosorbent assay.
RESULTS: It was established that in patients with OA, as well as after suffering from SARS-CoV-2 infection, an increase in the plasma levels of IL-1β was observed against the background of a decrease in the levels of IL-4, IL-8, IL-10, IL- 12β, TNF-α and IFN-γ, compared to the healthy controls. COVID-19 more significantly influenced the plasma levels of pro-inflammatory cytokines IL-1β and IL-12β.
CONCLUSIONS: The results indicate the imbalance of pro- and anti-inflammatory cytokines in the plasma in patients with OA for a long post-COVID. Сhanges in the levels of inflammatory mediators suggest distinct immunoregulatory mechanisms involved in the pathogenesis of both joint pathology and systemic disorders caused by SARS-CoV-2.


KEY WORDS: Cytokines; Osteoarthritis; COVID-19; SARS-CoV-2; Inflammation

top of page